Author
Listed:
- Charlotte Welinder
- Göran B Jönsson
- Christian Ingvar
- Lotta Lundgren
- Bo Baldetorp
- Håkan Olsson
- Thomas Breslin
- Melinda Rezeli
- Bo Jansson
- Thomas E Fehniger
- Thomas Laurell
- Elisabet Wieslander
- Krzysztof Pawlowski
- György Marko-Varga
Abstract
Globally, malignant melanoma shows a steady increase in the incidence among cancer diseases. Malignant melanoma represents a cancer type where currently no biomarker or diagnostics is available to identify disease stage, progression of disease or personalized medicine treatment. The aim of this study was to assess the tissue expression of alpha-synuclein, a protein implicated in several disease processes, in metastatic tissues from malignant melanoma patients. A targeted Selected Reaction Monitoring (SRM) assay was developed and utilized together with stable isotope labeling for the relative quantification of two target peptides of alpha-synuclein. Analysis of alpha-synuclein protein was then performed in ten metastatic tissue samples from the Lund Melanoma Biobank. The calibration curve using peak area ratio (heavy/light) versus concentration ratios showed linear regression over three orders of magnitude, for both of the selected target peptide sequences. In support of the measurements of specific protein expression levels, we also observed significant correlation between the protein and mRNA levels of alpha-synuclein in these tissues. Investigating levels of tissue alpha-synuclein may add novel aspect to biomarker development in melanoma, help to understand disease mechanisms and ultimately contribute to discriminate melanoma patients with different prognosis.
Suggested Citation
Charlotte Welinder & Göran B Jönsson & Christian Ingvar & Lotta Lundgren & Bo Baldetorp & Håkan Olsson & Thomas Breslin & Melinda Rezeli & Bo Jansson & Thomas E Fehniger & Thomas Laurell & Elisabet Wi, 2014.
"Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay,"
PLOS ONE, Public Library of Science, vol. 9(10), pages 1-9, October.
Handle:
RePEc:plo:pone00:0110804
DOI: 10.1371/journal.pone.0110804
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0110804. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.